Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Current Assets (2016 - 2025)

Standard Biotools (LAB) has disclosed Current Assets for 16 consecutive years, with $454.3 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 20.85% to $454.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $454.3 million through Dec 2025, up 20.85% year-over-year, with the annual reading at $454.3 million for FY2025, 20.85% up from the prior year.
  • Current Assets for Q4 2025 was $454.3 million at Standard Biotools, down from $472.4 million in the prior quarter.
  • The five-year high for Current Assets was $547.6 million in Q1 2024, with the low at $72.1 million in Q4 2021.
  • Average Current Assets over 5 years is $271.1 million, with a median of $218.9 million recorded in 2022.
  • The sharpest move saw Current Assets crashed 40.11% in 2021, then skyrocketed 220.79% in 2022.
  • Over 5 years, Current Assets stood at $72.1 million in 2021, then surged by 189.76% to $208.8 million in 2022, then decreased by 24.23% to $158.2 million in 2023, then soared by 137.58% to $375.9 million in 2024, then grew by 20.85% to $454.3 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $454.3 million, $472.4 million, and $506.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.